Heparin-Induced Thrombocytopenia and Thrombosis

BACKGROUND: Patients with acute medical illnesses are at prolonged risk for venous thrombosis. However, the appropriate duration of thromboprophylaxis remains unknown. METHODS: Patients who were hospitalized for acute medical illnesses were randomly assigned to receive subcutaneous enoxaparin (at a dose of 40 mg once…

• NİGAR GÜLFER OKUMUŞ

BACKGROUND: Patients with acute medical illnesses are at prolonged risk for venous thrombosis. However, the appropriate duration of thromboprophylaxis remains unknown. METHODS: Patients who were hospitalized for acute medical illnesses were randomly assigned to receive subcutaneous enoxaparin (at a dose of 40 mg once…

• HÜRREM GÜL ÖNGEN

BACKGROUND: Patients who are hospitalized for medical illness remain at risk for venous thromboembolism after discharge, but the role of extended thromboprophylaxis in the treatment of such patients is a subject of controversy. METHODS: In this randomized, double-blind trial, medically ill patients who were at increas…

• KEMAL CAN TERTEMİZ

BACKGROUND: Patients who are hospitalized for medical illness remain at risk for venous thromboembolism after discharge, but the role of extended thromboprophylaxis in the treatment of such patients is a subject of controversy. METHODS: In this randomized, double-blind trial, medically ill patients who were at increas…

• ÖZNUR YILDIZ

BACKGROUND: Patients who are hospitalized for medical illness remain at risk for venous thromboembolism after discharge, but the role of extended thromboprophylaxis in the treatment of such patients is a subject of controversy. METHODS: In this randomized, double-blind trial, medically ill patients who were at increas…

• NURHAN KÖKSAL

The pathogenetic role and the clinical importance of the presence of antiphospholipid antibodies (APAs) in patients with immune thrombocytopenic purpura (ITP) are not clear. In this study, the prevalence and clinical significance of APAs were investigated in patients with ITP. Eighty-two newly diagnosed ITP patients w…

• MEHMET TURGUT

No abstract yet.

• ERCAN TÜRKMEN

No abstract yet.

• HAYRİYE SAYARLIOĞLU
• MELDA DİLEK

No abstract yet.

• SÜLEYMAN TÜREDİ

No abstract yet.

• OĞUZ EROĞLU

No abstract yet.

• MURAT TOPBAŞ

No abstract yet.

• SÜLEYMAN CANER KARAHAN